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INTRODUCTION

Abstract—As part of the National Institutes of Health Toolbox
initiative, we developed a low-cost, easy-to-administer, and
time-efficient test of vestibular and visual function. A computerized test of dynamic visual acuity (cDVA) was used to measure the difference in visual acuity between head still and
moving in yaw. Participants included 318 individuals, aged 3
to 85 years (301 without and 17 with vestibular pathology).
Adults used Early Treatment of Diabetic Retinopathy Study
(ETDRS) optotypes; children used ETDRS, Lea, and HOTV
optotypes. Bithermal calorics, rotational chair, and light box
testing were used to validate the cDVA. Analysis revealed that
the cDVA test is reliable for static (intraclass correlation coefficient [ICC]  0.64) and dynamic (ICC  0.43–0.75) visual
acuity. Children younger than 6 years old were more likely to
complete cDVA with Lea optotypes, but reliability and correlation with ETDRS was better using HOTV optotypes. The high
correlation between static acuity and light box test scores (r =
0.795), significant difference of cDVA scores between those
with and without pathology (p  0.04), and the good to excellent sensitivity (73%) and specificity (69%) establish that the
cDVA is a valid and reliable measure of visual acuity when the
head is still and moving, as well as a good proxy of vestibular
function to yaw rotation.

The goal of the National Institutes of Health (NIH)
Toolbox initiative is to develop a valid set of instruments
that measure motor, sensory, cognitive, and emotive
functions for large-scale epidemiological and clinical trials and studies in subjects aged 3 to 85 years [1]. An
important mandate of this goal was to develop instruments that could be administered with minimal training

Abbreviations: BVH = bilateral vestibular hypofunction,
cDVA = computerized test of dynamic visual acuity, DVA =
dynamic visual activity, E-ETDRS = electronic Early Treatment
of Diabetic Retinopathy Study, ENG = electronystagmography,
ETDRS = Early Treatment of Diabetic Retinopathy Study, EVA
= electronic visual acuity, ICC = intraclass correlation coefficient, NIH = National Institutes of Health, SD = standard deviation, SVA = static visual acuity, UVH = unilateral vestibular
hypofunction, VH = vestibular hypofunction, VOR = vestibular
ocular reflex.
*Address all correspondence to Rose Marie Rine, PT, PhD;
Specialty Therapy Source, Research, 12948 Palmetto Glade
Dr, Jacksonville, FL 32246; 904-762-8419; fax: 904-2215741. Email: specialtytherapy@bellsouth.net
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by nonclinical persons. For the sensory domain, a joint
effort was invested by the vestibular and vision function
teams to develop a single tool that would be useful for
testing both senses. A select group of clinicians and basic
scientists* served on separate vestibular and vision teams
to identify appropriate tests for their respective sensory
area, followed by joint meetings to identify areas of testing overlap between the two teams. The documentation
of an increasing need for tests that can identify vestibular
and/or visual impairments throughout the lifespan supports the development of tools to meet that need.
The vestibular system is an integral component of
human sensory perception, including the perception of
angular and linear motion. It provides the brain with both
sensory afference and motor efference. Putative vestibular
impairments affect 35 percent of U.S. adults over 40 years
old [2], with approximately 8 million U.S. adults reporting chronic balance problems [3]. Aside from imbalance,
consequences of vestibular deficits also include gaze
instability and increased risk for falls [4]. Similar problems exist in pediatric populations. Recently, O’Reilly et
al. completed a review of pediatric patients seen over a
4-year period with a chief complaint of dizziness or
imbalance [5]. Of those seen by specialists in otolaryngology,
35 percent had confirmed vestibular disorders. Casselbrant et al. reported that balance and vestibular problems
persist in children with a history of chronic middle ear
effusion after the resolution of the effusion [6]. Together,
growing evidence suggests that a significant percentage
of adults and children have vestibular deficits, and the
incidence in children is underestimated [7–8]. Part of the
challenge in identifying the population with vestibular
hypofunction (VH) is the existence of a significant time
delay from the onset of symptoms to appropriate referral.
This is in part caused by the lack of screening tools that
can be used by nonspecialists to identify those individuals who should be referred for specialized testing and
treatment.
Vision is a complex sensation that provides a personal representation of an individual’s surrounding environment. With the aging of the U.S. population,
evaluation and treatment of age-related changes in

*Vestibular

Team: R. M. Rine, M. Schubert, S. Whitney, N. Shepard,
D. Wrisley, G. Jacobsen, J. Carey, J. Slotkin, H. Hoffman. Vision Team:
R. Varma, R. McKean-Cowdin, K. Cruickshanks, R. Hays, C. Johnson,
M. Maguire, R. Massof, C. Owsley, M. Repka, S. Vitale, M. Wall.

vision-related diseases will be of growing importance in
the next several decades. It is estimated that more than
150 million people in the U.S. general population wear
corrective lenses to compensate for visual impairment
caused by refractive error [9], which may include myopia, hyperopia, astigmatism, and presbyopia. Other relatively common disease-related causes of visual
impairment include age-related macular degeneration,
cataracts, diabetic retinopathy, and glaucoma. Studies to
prevent and evaluate treatment for these conditions will
be of increasing value because the number of people with
vision impairment from age-related eye disease is
expected to double in the next three decades [9].
Both the vestibular and vision teams were given the
task of developing a test that was (1) limited in number of
tests and/or demands on the study participants, (2) inexpensive, (3) time efficient, (4) portable, (5) a valid indicator of gaze stability and vision acuity, (6) able to be
performed in subjects aged 3 to 85 years, and (7) capable
of automated scoring and storing of data. The exclusion
criteria for tests to be selected were (1) reliance on selfreport of symptoms, (2) high cost, (3) requirement of
examiner expertise, or (4) lack of psychometric strength
(i.e., sensitivity, specificity, validity). Based on a comprehensive review of available tests and existing literature,
the vestibular team developed two separate tests: one that
isolates the vestibular system’s contribution to gaze stability (vestibular ocular reflex [VOR]) and one that isolates the vestibular system’s contribution to postural
control. For the purpose of this article, we will only discuss VOR measurement.
The test chosen for VOR examination was a computerized test of dynamic visual acuity (cDVA) [10–11]. For
the vision team, computerized visual acuity testing was
also deemed the best way to measure visual acuity.
Therefore, the vestibular and vision teams agreed to
merge their efforts into a single test of static visual acuity
(SVA). While current versions of cDVA are available,
they are expensive, require examiner expertise, and have
no pediatric correlate. Consequently, efforts in software
and hardware development were made to build a new test
for use with children and adults that incorporated SVA
and dynamic visual acuity (DVA) to evaluate peripheral
VH for the vestibular team and visual resolution for the
vision team.
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BACKGROUND
Dynamic Visual Acuity
The semicircular canals and otolith organs of the
peripheral vestibular end organ are essential for maintaining gaze and gait stability during head motion. This is
achieved by efference from the VOR and the vestibulospinal reflexes. Damage to semicircular canals and/or
otolith organs causes impaired visual acuity during head
rotation (DVA); impaired balance and postural control;
and symptoms of vertigo, falling, nausea, and disorientation [10–18]. In addition to these symptoms, children
with VH also experience a progressive motor delay with
deleterious consequences on social development and
educational performance [7,19]. However, lack of availability of low-cost, easy-to-administer tools to screen for
VH has limited its identification. The NIH Toolbox
cDVA was developed to address this shortcoming.
The DVA test measures the ability to see clearly during head rotation. Scores reflect the difference in visual
acuity between stable head and moving head [10–11]. At
velocities <100 °/s, the ability to maintain gaze during
head rotation is enabled by visual pursuit and the VOR
[20]. For head velocities >100 °/s, the VOR is the primary contributor for detecting head rotation and maintaining stable gaze [21]. Herdman et al. were the first to
develop a cDVA by flashing the letter E optotype whenever head velocities were between 120 and 180 °/s [10].
They presented optotypes in progressively smaller sizes,
five at each acuity level, until the subject incorrectly
identified five optotypes at a single line of acuity. A rate
sensor mounted on a headband worn by the subject monitored active head velocity. The investigators reported
good reliability, excellent sensitivity and specificity
(94%), and significant effect of age in both nondisabled
controls and patients with VH. In a separate study, Schubert et al. examined the use of a vertical DVA test and
also reported excellent reliability (intraclass correlation
coefficient [ICC] = 0.94) for patients with VH, but poor
sensitivity in identifying unilateral VH (UVH) loss (ICC =
0.23) [22]. This sensitivity improved to detect bilateral
VH (BVH; ICC = 0.55), with the test having excellent
specificity to rule out vestibular pathology of any type
(ICC = 0.90). Each of these aforementioned tests was
computerized but limited to testing adults (mean ± standard deviation [SD] = 50.6 ± 17.0 years) and did not have
a validated SVA test.

Rine and Braswell developed a noncomputerized,
clinical version of the horizontal DVA test for use with
children [23]. Images included Lea symbols (circle,
square, house, or apple; Figure 1(a)), posted on a 15-line
vision optotype chart [24]. Children aged 3 to 15 years
with (n = 11) and without (n = 76) BVH participated.
Subjects initially completed the SVA test [25]. For the
DVA test, the child’s head was passively moved in the
horizontal plane, using a metronome to assure a velocity
of 2 Hz. These investigators reported good to excellent
reliability (ICC = 0.84) for horizontal DVA and excellent
sensitivity and specificity (97%). However, this study
was limited because a significant amount of examiner
training was required and the sample was limited to those
children with BVH. While UVH is more common than
BVH in adults, we are unaware of the incidence of UVH
in children or its effect on DVA in children.
Static Visual Acuity
SVA tests measure impairments in visual resolution
that can be caused by blurring of the retinal image, neural

Figure 1.
Vision optotypes used included (a) Lea, (b) Early Treatment of
Diabetic Retinopathy Study, and (c) HOTV.
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processing disorders, or damage to neurons in the retina
or other parts of the visual pathway. The gold standard
for visual acuity testing in adults is the Early Treatment
of Diabetic Retinopathy Study (ETDRS) optotype [26–
27]. The ETDRS optotype was developed to evaluate
changes in vision following panretinal photocoagulation
in patients with diabetic retinopathy [27]. The test is
administered in a standardized way, using visual acuity
optotypes illuminated on a light box, resulting in quantitative visual acuity test results. It was designed to allow
for comparison of data across research studies and is recommended by the National Academy of Sciences and the
American National Standards Institute. The ETDRS
optotypes include the same number of letters per row
with equal spacing of letters and rows (0.1 logMAR
between each row), with the individual rows balanced for
letter difficulty. The ETDRS optotyes use 10 letters: C,
D, H, K, N, O, R, S, V, and Z (Figure 1(b)). Scoring is
completed on a logarithmic scale.
SVA testing in children (5–12 years old) has traditionally used the letters H, O, T, and V (Figure 1(c)),
which replaced the ETDRS optotype letters in an attempt
to improve testability in younger age groups [28]. Protocols using picture optotypes have also been used with
high success rates (e.g., testability) but have been shown
to overestimate visual acuity in some children with visual
impairment [29]. Several investigators have reported that
completion rates are better using symbols, as in the Lea
optotypes [25,30], but a concern has been its sensitivity
to test amblyopia. The use of HOTV optotypes was standardized in the Amblyopia Treatment Study, during
which the protocol was found to have high testability and
test-retest reliability in children aged 3 to 7 years [31].
The Amblyopia Treatment Study procedure was modified for an electronic visual acuity (EVA) tester to simplify the testing procedure and decrease testing
variability [32]. HOTV testability in developmentally
normal children was found to be 100 percent in 5- to 12year-olds but was not tested in younger children. An
EVA testing system has also been developed (electronic
ETDRS [E-ETDRS] optotype) that uses a testing algorithm that runs on the EVA tester [32–35]. In a study
comparing E-ETDRS optotypes with the HOTV optotype, investigators found that children had better test
results for HOTV optotypes compared with E-ETDRS
optotypes (median difference = 0.06 logMAR or 3 letters
on an optotype with 5 letters per line, p = 0.0001) when

including children with normal eyes, eyes with refractive
error, or amblyopic eyes [28].
The purpose of this project was to develop an inexpensive, portable, and psychometrically sound measure
of visual acuity during still head and head in motion.
Specifically, the objectives were to (1) determine the
optimal optotype for use with young children, (2) establish the reliability of the DVA and SVA tests, and (3)
determine the validity of the DVA and SVA tests.

METHODS
Subjects
We enrolled 318 subjects (17 with and 301 without
vestibular pathology) in the study. To provide sufficient
sample size to allow for repeat testing to determine optimal optotype in children, a larger portion of the sample
was aged 12 or younger (Table 1). VH was confirmed by
bithermal caloric (adults: >20% asymmetry) or rotational
chair (children: 2 SDs below the normative age-matched
data collected in this laboratory) tests. All children completed rotary testing. The types of pathology in this group
were BVH secondary to infection (n = 10) or mild head
trauma (n = 1). Only adults with suspect pathology completed bithermal caloric testing to confirm UVH: five
caused by viral assault and one deafferented because of
removal of vestibular schwannoma. Screening confirmed
exclusion criteria, which included preexisting central nervous system disorder, cervical spine pathology, and any
oculomotor impairment.
Instrumentation
Custom software was written in Python and C++.
Hardware included a 2 GHz Intel Dual central processing
unit laptop with 2 GB of RAM (IBM Thinkpad; Armonk,
New York). The laptop was connected to a 1440 × 900
resolution monitor that displayed the optotypes. The
operator used the built-in laptop display. A single-axis
rate sensor (O-Navi; Vista, California) used to detect horizontal head rotation was attached to a soft bicycle light
strap and secured to the head (Figure 2). The rate sensor
triggered the software to flash an optotype only when
head velocity met or exceeded 180 °/s. During SVA testing, optotypes were presented one at a time and continuously until the subject identified the optotype (no time
limit). During cDVA, the optotype flashed on the screen
for 83 ms only when the head moved 180 °/s. Optotype
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Table 1.
Subject demographics, n (%).

Demographic
Female
Age (yr)
3
4
5
6
7
8
9
10
11
12
13–17
18
18–35
36–65
66–85
Race/Ethnicity
American Indian
Asian
Black or African American
White
More Than One Race
Unknown/Not Reported
Hispanic

All (n = 318)
164 (51.6)

Nondisabled (n = 301)
154 (51.2)

Vestibular Pathology (n = 17)
10 (58.8)

21 (6.6)
34 (10.7)
21 (6.6)
23 (7.2)
30 (9.4)
27 (8.5)
27 (8.5)
18 (5.7)
19 (6.0)
20 (6.3)
24 (7.5)
54 (17.0)
16 (5.0)
27 (8.5)
11 (3.5)

21 (7.0)
34 (11.3)
21 (7.0)
22 (7.3)
28 (9.3)
27 (9.0)
25 (8.3)
17 (5.6)
18 (6.0)
18 (6.0)
22 (7.3)
48 (16.0)
16 (5.3)
22 (7.3)
10 (3.3)

0 (0)
0 (0)
0 (0)
1 (5.9)
2 (11.8)
0 (0)
2 (11.8)
1 (5.9)
1 (5.9)
2 (11.8)
2 (11.8)
6 (35.3)
0 (0)
5 (29.4)
1 (5.9)

2 (0.6)
8 (2.5)
12 (3.8)
257 (80.8)
11 (3.5)
28 (8.8)
23 (7.2)

2 (0.7)
8 (2.7)
12 (4.0)
248 (82.4)
9 (3.0)
22 (7.3)
21 (7.0)

0 (0)
0 (0)
0 (0)
9 (52.9)
2 (11.8)
6 (35.3)
2 (11.8)

size ranged from 20/10 to 20/800. The software calculated an acuity score (in logMAR) assuming 100 optotypes were viewed using the formula: 1.7 – (0.02 ×
number correct) for SVA and DVA tests. We calculated
the cDVA score from these measures by subtracting SVA
from cDVA for each side.

Figure 2.
Dynamic visual acuity headgear. Rate sensor attached to
headband.

Data Collection
Subjects sat 12.5 ft away from the viewing screen at
their eye level. The SVA test begins with an initial
“quick” screening at size 20/50 and presents a single random letter per size (in steps of 0.1 logMAR), either going
smaller until one is identified incorrectly or larger until
one is identified correctly. The test then presents five letters
per line size, beginning with the smallest size answered
correctly during screening. If any letter is missed at the
largest size seen, the next largest level is added. If three
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or more letters are correct at the smallest size seen, the
next smallest level is added. The subject always sees all
five letters for each line size. Letters from the largest level
in the test are always shown first, working down to the
smallest level. Testing stops when three or more letters
are missed at the smallest level or the subject reaches the
20/10 level. The DVA test follows the same procedure,
except it avoids the screening portion and starts three line
sizes larger than the SVA screening. However, we performed training trials to assure correct head movement.
The operator enters the subject’s responses. The software
records the history of all optotypes displayed and the participants’ responses.
Testing was performed first with the head still (SVA)
and again with the head moving (DVA) to the right (two
trials) and then to the left (one trial). The first trial with
rotation to the right was considered training for all subjects. We discarded scores from this trial and used them
to control for learning effect [10–11].
Subjects self-generated the horizontal head rotations
and were instructed to “move your head side to side as if
saying no.” Children completed training trials for DVA
testing until they obtained 80 percent accuracy (4/5 correct optotypes). Young children responded verbally or by
pointing to a card with the optotypes on it (at a size of 20/
100). Subjects (n = 299) completed each test sequence
twice to examine reliability.
For all subjects over 12 years old, we used the
ETDRS optotype. To determine the optimal optotype set
for use with children, we used three optotype sets (Lea,
HOTV, and ETDRS); for subjects aged 3 to 6 years, we
used both Lea symbols and HOTV optotypes, and for subjects aged 7 to 12 years, we completed tests using all three
optotypes. Presentation sequence of optotypes for these
groups was performed using a random block design.
To encourage participation by the youngest children,
the examiners used reward stickers. Often, young children tend to avoid objects placed on their head, so the
examiners offered “hats” (e.g., crown, pirate hat, or
themed baseball cap) that could be attached to the head
gear (Figure 3). Children were able to take their hat with
them when testing was complete.
ETDRS light box acuity testing was completed by all
subjects 7 years old to examine validity of the computerized SVA test. We asked subjects to read each letter of
an ETDRS optotype placed 12.5 ft away, backlit with a
light box. The test was complete when the subject missed
three out of five optotypes at a line size (in logMAR) or

Figure 3.
Hat incentive for children. To encourage participation and wearing
rate sensor, paper hats were attached to headband. Rate sensor
was concealed to minimize any anxiety and curiosity.

read the entire optotype [27]. The SVA score was the line
size (logMAR) just above this.
Statistical Analysis
We estimated test-retest reliability using ICCs within
each of the age groups. To evaluate agreement between
acuity scores based on different optotypes and tests, we
computed ICCs between the pairs of measures (Lea,
HOTV, ETDRS) within each age group and collapsed
across age groups. We evaluated usability of each measure among children by examining the number able to successfully complete each test. We examined the
associations of each measure with the relevant gold standard. For children, we used data from the rotational chair
as a criterion reference; for adults, we used electronystagmography (ENG) as the reference to validate those subjects with vestibular pathology. In addition, we used a
prior-established cDVA [36] to establish validity
(sensitivity and specificity) in adults. For children, we
used rotary test results to establish validity. To compare
cDVA scores between those who did and did not pass the
gold standard examination (evaluate construct validity),
we used two-sample t-tests. We calculated effect sizes
(mean difference divided by pooled SD) for all group
comparisons to aid interpretation.
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RESULTS
Demographics and Descriptives
Of the sample, 52 percent was female and 7 percent
was Hispanic (Table 1). Of the 318 total participants, a
small sample (n = 17) had a diagnosed vestibular pathology.
Most of the individuals with vestibular pathology (14/17;
82%) were 9 years old.
Completion rates differed in the youngest groups
(Table 2). For SVA testing, children 3 to 4 years old more
successfully completed the test using the Lea optotypes
instead of the HOTV optotypes.
Reliability
The reliability of SVA testing for each optotype
depended on the optotype used but ranged from excellent
to good (ICC = 0.89, 0.91, and 0.84 for Lea, HOTV, and
ETDRS, respectively; Table 3). Reliability for cDVA
was acceptable for the HOTV and ETDRS optotypes but
not the Lea optotype (ICC = 0.55 for HOTV, 0.65 for
ETDRS, 0.43 for Lea; Table 3). The difference in reli-

ability of the optotypes was more pronounced in DVA
testing (Table 3).
The following correlation of SVA scores between
optotypes existed: Lea and HOTV = moderate to excellent (r = 0.58–0.98; overall r = 0.88); Lea and ETDRS =
fair to excellent (r = 0.41–0.96; overall r = 0.90), and
HOTV and ETDRS = good to excellent (r = 0.72–0.97;
overall r = 0.93).
Validity
Sensitivity and specificity of cDVA was fair to excellent (calculations based on ETDRS optotypes only [n =
210]; Table 4). For children, scores achieved by those
with and without VH were significantly different (p 
0.001; effect size = 0.7; Figure 4). In adults, those who
failed the previously established cDVA differed significantly from those who did not (p  0.001; effect size =
1.9; Figure 4). The agreement between the computerized
version of SVA and light box visual acuity scores was
good (r = 0.795; p  0.001; Figure 5).

Table 2.
Success rates for completion of testing by age and optotype. All other age groups achieved 100 percent completion rates.

Static Visual Acuity (%)
Lea
HOTV
81
76
94
86

Age (yr)
3
4

Dynamic Visual Acuity (%)
Lea
HOTV
70
40
85
50

Table 3.
Reliability of visual acuity measures.

Measure
Static Visual Acuity
Lea
HOTV
ETDRS
Dynamic Visual Acuity
Lea (left)
Lea (right)
Lea (average)
HOTV (left)
HOTV (right)
HOTV (average)
ETDRS (left)
ETDRS (right)
ETDRS (average)

All

Age 3–4
(n = 37 to 50)

ICC (95% CI)
Age 5–6
Age 7–12
(n = 43 to 44) (n = 133 to 141)

0.89 (0.86, 0.92)
0.91 (0.88, 0.93)
0.84 (0.79, 0.88)

0.64 (0.35, 0.82)
0.73 (0.47, 0.87)
—

0.75 (0.53, 0.87)
0.61 (0.32, 0.80)
—

0.38 (0.25, 0.50)
0.29 (0.15, 0.42)
0.43 (0.31, 0.54)
0.43 (0.30, 0.54)
0.46 (0.34, 0.57)
0.55 (0.44, 0.64)
0.53 (0.42, 0.63)
0.69 (0.61, 0.76)
0.65 (0.56, 0.73)

0.39 (0, 0.70)
0.09 (0, 0.46)
0.32 (0, 0.63)
0.57 (0.21, 0.79)
0.46 (0.06, 0.73)
0.63 (0.30, 0.83)
—
—
—

0.45 (0.10, 0.70)
0.50 (0.16, 0.73)
0.52 (0.19, 0.74)
0.63 (0.35, 0.81)
0.18 (0, 0.51)
0.51 (0.18, 0.74)
—
—
—

Age 13–17
(n = 24)

Age 18–76
(n = 50 to 54)

0.92 (0.89, 0.94)
0.93 (0.90, 0.95)
0.85 (0.80, 0.89)

—
—
0.74 (0.50, 0.88)

—
—
0.81 (0.62, 0.91)

0.27 (0.11, 0.42)
0.22 (0.05, 0.37)
0.34 (0.18, 0.48)
0.28 (0.12, 0.43)
0.46 (0.32, 0.58)
0.48 (0.34, 0.60)
0.38 (0.23, 0.52)
0.42 (0.27, 0.55)
0.48 (0.34, 0.60)

—
—
—
—
—
—
0.56 (0.22, 0.78)
0.73 (0.48, 0.87)
0.75 (0.51, 0.88)

—
—
—
—
—
—
0.44 (0.07, 0.70)
0.76 (0.53, 0.89)
0.58 (0.25, 0.79)

Note: Age range is provided due to varied number of subjects that completed retest within each optotype.
CI = confidence interval, ETDRS = Early Treatment of Diabetic Retinopathy Study, ICC = intraclass correlation coefficient.
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Table 4.
Sensitivity and specificity (using Early Treatment of Diabetic Retinopathy Study optotype) of computerized test of dynamic visual acuity
(cDVA).

cDVA
Pass
Fail
Total

No
135
60
195

Pathology (n)
Yes
4
11
15

Total
139
71
210

Note: Sensitivity = 73%; specificity = 69%.

DISCUSSION
The cDVA created for the NIH Toolbox initiative is a
valid measure of SVA, DVA, and VH. For children,
cDVA reliability is moderate when using the ETDRS
optotype and fair when using the Lea and HOTV optotypes. This might be because of the minimal variation in
scores, since most subjects with pathology were >9 years
old and thus were tested using only the ETDRS optotype.
cDVA is a functional measure of VOR and will not
replace the current standard of clinical vestibular function testing (i.e., bithermal caloric or rotary tests with

ENG). This is in part because of the test being performed
using active head rotations, which are known to recruit
strategies to assist gaze stability, different from the VOR
[37]. However, our version of the cDVA would be a useful means to screen visual acuity and VOR, particularly
in large population-based studies.
Similar to prior reports [25,30], we had more success
using the Lea optotypes for children <5 years old. This
was particularly evident in DVA testing, which may be
because of the increased difficulty of the dual task of
moving the head and identifying a symbol. However, scores
from HOTV had a higher correlation with the ETDRS

Figure 4.
Comparison of computerized testing of dynamic visual acuity (cDVA) score between those with and without pathology. cDVA score
(dynamic visual acuity score – static visual acuity score, in logMAR) differed significantly between those with and without pathology
in both younger and older age groups.
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Figure 5.
Correlation of computerized static visual acuity (SVA) and light
box testing scores. SVA scores (in logMAR) attained on computerized test and light box test were highly correlated (r =
0.795; p < 0.001).

optotype. These results suggest that the ideal optotype for
children <6 years old is the HOTV optotype for SVA.
However, if cDVA is of primary interest to investigators,
the Lea optotype is optimal for success rates with very
young children. Some of the challenges we experienced
that influenced testability in children were that they were
not comfortable or secure identifying letters, they were
concerned they had made an error (or at least felt they did
and did not want to continue), or they became bored with
the task. All children were comfortable identifying the
symbols and thus did not feel challenged until the optotype became small. With a dual discomfort level (letters
and size with HOTV and ETDRS optotypes), children
often wanted to stop all testing, with participation in the
dynamic component adding a third challenge. Therefore,
depending on the purpose of the data, cDVA in children
should use the optotype that affords the most success
(e.g., Lea optotype). Note that for this study, children
completed testing of two or three different optotypes. This
would not be the case in the typical clinical setting. In our
experience, success in testing young children is maximized by keeping an upbeat, positive approach and using
plenty of encouragement, applauding all responses.
We were able to complete the cDVA within 5 min for
most subjects. Occasionally, testing in younger children
required more demonstration, breaks, and rests and could
thus require 7 min. This may be greatly influenced by the
skill of the investigator working with children even
though the protocol is computerized.

Both vestibular and visual functions are expected to
be critical components of the functional status of individuals of all ages. This is primarily because of the growing evidence of vestibular and visual impairments in
adults and children [2–3,5,7,38]. As we age, vestibular
afferent neurons die and function similarly becomes
impaired [39]. Refractive error is also a common condition in the general population, and the level of visual
impairment caused by age-related diseases is expected to
increase in the general population over the next several
decades as the age distribution shifts toward greater numbers of individuals in older age groups. A readily available, inexpensive tool that enables screening of visual
acuity and vestibular function by individuals with minimal training is important for healthcare and research.

LIMITATIONS
The limited number of subjects with vestibular
pathology younger than 6 years old limits the generalization of sensitivity and specificity reported to those older
than 6 years old. This, and the lack of gold standard testing of vestibular function in adults without vestibular
pathology, may have affected results presented here. Furthermore, most subjects had visual acuity at or above 20/
20. Further study is warranted that includes individuals
with vestibular pathology across all ages, with gold standard testing of vestibular function of those with and without vestibular pathology, and those with visual acuity
impairments to comprehensively establish the validity of
this test.

CONCLUSIONS
Screening for vestibular function and visual acuity
requires specialized training and expensive equipment
that is not typically portable. Based on results presented
here, the cDVA developed for use in the NIH Toolbox
yields reliable and valid measures of both SVA and DVA.
The test is inexpensive, portable, and can be completed
by individuals aged 3 to 85 years. No special expertise in
visual or vestibular testing is needed, and the test can be
completed within 5 min. This makes it an optimal tool to
screen for vestibular functional status by clinicians in various settings and investigators alike. Continuing research
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is underway to establish a normative database for individuals aged 3 to 85 years.
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